State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019
This bill authorizes health insurance issuers to jointly negotiate the prices for prescription drugs with the manufacturers of such drugs.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2019-05-15 | Committee | Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. | House committee actions |
| 2019-04-02 | IntroReferral | Referred to the House Committee on the Judiciary. | House floor actions |
| 2019-04-02 | IntroReferral | Introduced in House | Library of Congress |